HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 59 filers reported holding HERON THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $406,000 | +13.4% | 25,154 | -2.6% | 0.00% | +100.0% |
| Q2 2017 | $358,000 | +8.5% | 25,835 | +17.6% | 0.00% | 0.0% |
| Q1 2017 | $330,000 | +27.4% | 21,972 | +11.3% | 0.00% | 0.0% |
| Q4 2016 | $259,000 | -27.5% | 19,739 | -4.8% | 0.00% | 0.0% |
| Q3 2016 | $357,000 | -4.5% | 20,730 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $374,000 | +4.8% | 20,730 | +10.2% | 0.00% | 0.0% |
| Q1 2016 | $357,000 | -30.4% | 18,810 | -2.1% | 0.00% | 0.0% |
| Q4 2015 | $513,000 | +12.5% | 19,215 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $456,000 | -8.6% | 18,707 | +16.9% | 0.00% | 0.0% |
| Q2 2015 | $499,000 | +102.8% | 15,999 | -5.5% | 0.00% | +100.0% |
| Q1 2015 | $246,000 | +39.0% | 16,936 | -3.8% | 0.00% | 0.0% |
| Q4 2014 | $177,000 | +20.4% | 17,597 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $147,000 | -17.4% | 17,597 | +22.1% | 0.00% | 0.0% |
| Q2 2014 | $178,000 | – | 14,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |